MILLER David,MACLEOD Angus,DEL RIO GANCEDO Susana,STRATFORD Samuel Alexander
申请号：
SI201930005
公开号：
SI3606909T1
申请日:
2019.04.23
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
The present invention relates to a sodium salt ofN-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide and to hydrates, solvates and polymorphic forms thereof. The present invention further relates to pharmaceutical compositions comprising this compound and the use of this compound in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
